Exchange: OTC·Updated 02:31 PM EDT
HEPA logo

HEPA Hepion Pharmaceuticals Inc

$0.142
$0.007
(5.18%)
Today
Mkt Cap$13.26M
Vol45,414.00

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
54

Neutral Sentiment

How do you feel about HEPA?

Discernment
$HEPA Out of all the horse shit they could have made up to raise funds and run the scam all over again they picked a drug that inhibits gambling. LOL. What's next another name change to make it appear like a new company? 😂
3
Gebinator
$HEPA yep, it turns out that $HEPA believes there's a market and unmet need to treat GAMBLING ADDICTION. INSERT YOUR OWN JOKE HERE: __________________________
1
Gebinator
$HEPA as per Google: Gravitas Life Sciences, LLC is a biotechnology research and development company recently acquired by Hepion Pharmaceuticals on October 9, 2026. Key Corporate History & Recent Deals • Previous Ownership: Formerly the biotech R&D arm of Canton Strategic Holdings, Inc. (NASDAQ: CNTN). • July 2026 Sale: Canton Strategic Holdings sold Gravitas Life Sciences to Gravitas Collective Corp., closing on July 17, 2026. • October 2026 Acquisition: Hepion Pharmaceuticals completed the acquisition of Gravitas Life Sciences for $2.0 million in cash plus 25 million shares (subject to a 19.99% issuance cap), alongside an additional $135,000 cash payment and a partial payoff/assumption of a note with Canton Strategic Holdings. • Leadership Impact: Sireesh Appajosyula, PharmD (former CEO of Gravitas Life Sciences) was appointed Chief Executive Officer of Hepion Pharmaceuticals effective October 9, 2026. • Pipeline: The transaction expands Hepion's immunology and inflammation pipeline.
1
_unavailable_
$HEPA - interesting movement in volume recently with today matching the earlier September spike
1

Advertisement|Remove ads.